GCLSX
Price
$24.13
Change
+$0.06 (+0.25%)
Updated
Jun 27 closing price
Net Assets
525.02M
RMFEX
Price
$58.76
Change
+$0.14 (+0.24%)
Updated
Jun 27 closing price
Net Assets
107.25B
Interact to see
Advertisement

GCLSX vs RMFEX

Header iconGCLSX vs RMFEX Comparison
Open Charts GCLSX vs RMFEXBanner chart's image
Goldman Sachs Large Cp Val Insghts Svc
Price$24.13
Change+$0.06 (+0.25%)
VolumeN/A
Net Assets525.02M
American Funds American Mutual R4
Price$58.76
Change+$0.14 (+0.24%)
VolumeN/A
Net Assets107.25B
GCLSX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCLSX vs. RMFEX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCLSX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 107B vs. GCLSX (525M). RMFEX pays higher dividends than GCLSX: RMFEX (1.58) vs GCLSX (0.72). GCLSX was incepted earlier than RMFEX: GCLSX (27 years) vs RMFEX (23 years). GCLSX (1.16) is less costly to investors than RMFEX (0.62). GCLSX is a more actively managed with annual turnover of: 206.00 vs. RMFEX (31.00). GCLSX has a lower initial minimum investment than RMFEX: GCLSX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 10.28 vs. GCLSX (-0.87). RMFEX return over 5 years is better than : 66.81 vs. GCLSX (37.42).
GCLSXRMFEXGCLSX / RMFEX
Total Expense Ratio1.060.62171%
Annual Report Gross Expense Ratio1.160.62187%
Fund Existence27 years23 years-
Gain YTD3.5057.80345%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets525M107B0%
Annual Yield % from dividends0.721.5846%
Returns for 1 year-0.8710.28-8%
Returns for 3 years19.1729.0266%
Returns for 5 years37.4266.8156%
Returns for 10 years54.7583.2066%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNSE8.680.30
+3.58%
Sensei Biotherapeutics Inc
XTNT0.630.01
+2.14%
Xtant Medical Holdings
FBP20.880.31
+1.51%
First BanCorp
SUZ9.30-0.08
-0.85%
Suzano SA
REPL9.33-0.13
-1.37%
Replimune Group